Taking it to the streets. Stockhouse.com: Taking it to the street
Fusionpower’s details
My Bullboard Posts
 
symbolsubjectdate & timerating
V.SSS
RE: Trillium Therapeutics Phase 1 Completed

?		 5/16/2013 6:12:09 PM
V.SSS
Trillium Therapeutics Phase 1 Completed

TTI-1612		 4/15/2013 7:15:45 PM
V.SSS
Old news

Trillium and Biogen Idec enter into global license agreement TORONTO, Jan. 12 /PRNewswire/ - Trillium Therapeutics Inc. (TTI), a biopharmaceutical company developing innovative immune-based biologics, today announced that it has entered into a de...		 3/21/2013 6:31:42 PM
V.SSS
Good news soon?????

Trillium Therapeutics		 3/20/2013 6:00:17 PM
V.SSS
Offering of Up to $3.5 Million of Units

Stem Cell Therapeutics Corp. (TSX VENTURE:SSS) ("SCT"), a life sciences company developing stem cell-related technologies, announced today that it intends to file a prospectus supplement in each of the Canadian provinces of British Colu...		 3/7/2013 6:11:51 PM      3
V.SSS
BioWorld

Stem Cell Therapy Moves to Reinvent Itself, Raise Value By Brian Orelli BioWorld Insight Contributing Writer After seeing its clinical program stall following the failure of a Phase IIb trial testing NTx-265 in acute stroke, Stem Cell Therapeutic...		 3/5/2013 8:38:22 PM      4
V.SSS
Profile

David Allan is lead director at DiaMedica, the founding chairman, and previous CEO of the public company, YM BioSciences , Executive Chairman of the public company Stem Cell Therapeutics Corp., and chairman of the private, Canadian company, AvidB...		 2/23/2013 8:09:21 PM      2
V.SSS
Impact of Stroke

About 795,000 Americans each year suffer a new or recurrent stroke. That means, on average, a stroke occurs every 40 seconds. Stroke kills more than 137,000 people a year. That's about 1 of every 18 deaths. It's the No. 4 cause of death. ...		 2/20/2013 8:23:16 PM      4
V.SSS
ClinicalTrials.gov processed this record on Februa

Stem Cell Therapeutics Corp NCT00938314 NTx®-265-CP-202-IS Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke Patients (REGENESIS-LED)		 2/19/2013 8:23:21 PM      4
V.SSS
News FDA cleared

Stem Cell Therapeutics Announces Joint-Venture Agreement With Reneu Inc. and Nexgen Medical Systems, Inc Novel Combination of Neural Stem Cell Technology & Direct-to-Brain Administration of Therapeutics via an FDA-Cleared Neurocatheter Press ...		 2/19/2013 5:13:58 PM      5
 
My Blogs
 
LATEST ENTRIES
No additional content to display.
 
 
Discover your inner journalist
 
Submit an article for editorial consideration. Find out more.
 
 
Company Showcase
 
View Sectors
 
 
 
Today's Feature  
View Now
 
Pacific North West Capital Corp.
Pacific North West Capital Corp. (TSX: PFN; OTCQX: PAWEF; Frankfurt: P7J) is a mineral exploration company focused on the discovery, exploration and development of PGM and nickel-copper sulphide deposits in geologically prospective regions in North America, particularly Canada. The Company's key asset is its 100% owned River Valley PGM Project in the Sudbury region of northern Ontario. The River Valley Project is one of North America's most advanced primary PGM deposits...